Share This Page
Drug Price Trends for LOESTRIN FE
✉ Email this page to a colleague
Average Pharmacy Cost for LOESTRIN FE
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| LOESTRIN FE 1-20 TABLET | 51285-0125-70 | 7.52460 | EACH | 2025-01-01 |
| LOESTRIN FE 1-20 TABLET | 51285-0125-70 | 6.87831 | EACH | 2024-12-18 |
| LOESTRIN FE 1-20 TABLET | 51285-0125-70 | 6.87831 | EACH | 2024-11-20 |
| LOESTRIN FE 1-20 TABLET | 51285-0125-70 | 6.87831 | EACH | 2024-10-23 |
| LOESTRIN FE 1-20 TABLET | 51285-0125-70 | 6.87831 | EACH | 2024-09-18 |
| LOESTRIN FE 1-20 TABLET | 51285-0125-70 | 6.87831 | EACH | 2024-08-21 |
| LOESTRIN FE 1-20 TABLET | 51285-0125-70 | 6.87831 | EACH | 2024-07-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Loestrin Fe
Overview of Loestrin Fe
Loestrin Fe is a low-dose oral contraceptive that combines ethinyl estradiol and norethindrone acetate, often used for birth control. It is available in various formulations, including Lo Loestrin Fe and Loestrin Fe 1/20, each with different dosages and components[3][4].
Market Assessment
Historical Sales and Market Trends
The global market for Loestrin Fe has seen steady demand due to its effectiveness as a birth control method. Historical sales data indicate a consistent market presence, with the drug being a part of the broader oral contraceptive market. The report by ResearchAndMarkets.com provides insights into the historical global sales and forecasts future sales from 2019 to 2021, highlighting the drug's market stability and growth potential[1].
Competitive Landscape
Loestrin Fe operates within a competitive market filled with other oral contraceptives. The drug's unique formulation and dosing regimen set it apart, but it still faces competition from other low-dose combined oral contraceptives. Understanding the competitive landscape is crucial for manufacturers and marketers to devise strategies to maintain market share and expand their customer base[1].
Product Details and Formulations
Lo Loestrin Fe
Lo Loestrin Fe is a specific formulation that includes a regimen of 24 days of tablets containing 10 mcg of ethinyl estradiol and 1 mg of norethindrone acetate, followed by 2 days of tablets containing 10 mcg of ethinyl estradiol, and finally 2 days of tablets containing ferrous fumarate 75 mg. This formulation is designed to minimize the amount of estrogen while maintaining efficacy[3].
Loestrin Fe 1/20
Loestrin Fe 1/20 is another formulation that contains 20 mcg of ethinyl estradiol and 1 mg of norethindrone acetate, along with iron. This formulation is also popular and is used for the same indication of preventing pregnancy[4].
Pricing and Cost Analysis
Current Pricing
The cost of Loestrin Fe formulations can be significant. For example, Lo Loestrin Fe (with iron biphasic 10 mcg-1 mg) can cost around $955 for a supply of 140 tablets, while Loestrin Fe 1/20 (with iron 20 mcg-1 mg) costs approximately $1,056 for the same quantity. These prices are for cash-paying customers and can vary depending on the pharmacy and any available discounts or coupons[2][4].
Discount Programs and Patient Assistance
To make the drug more affordable, various discount programs and patient assistance options are available. For instance, the Drugs.com Discount Card can save patients up to 80% on prescription medicines. Additionally, copay cards and savings programs offered by the manufacturer can reduce the cost per monthly prescription[2][4].
Regulatory and Patent Landscape
Approval and Regulatory Milestones
Loestrin Fe formulations have been approved by the FDA, with Lo Loestrin Fe receiving approval based on its safety and efficacy demonstrated in clinical trials. The FDA's review process included an assessment of the drug's Pearl Index, which measures its effectiveness in preventing pregnancy, and its safety profile, which was found to be acceptable[3].
Patent Expiry and Market Exclusivity
Understanding the patent expiry timeline and market exclusivity data is crucial for planning generic development and API procurement strategies. The report by ResearchAndMarkets.com provides detailed information on patents and market exclusivity, helping stakeholders navigate the legal landscape[1].
Sales Projections and Forecast
Historical and Forecasted Sales
The report from ResearchAndMarkets.com provides historical sales data and forecasts future sales for Loestrin Fe from 2019 to 2021. This data is essential for understanding the drug's market performance and predicting future growth. The forecast indicates a stable market with potential for growth, driven by the drug's efficacy and the ongoing demand for birth control methods[1].
SWOT Analysis
Strengths
- Efficacy and Safety: Loestrin Fe has been demonstrated to be safe and effective in clinical trials, making it a reliable choice for birth control.
- Unique Formulation: The drug's specific dosing regimen and low estrogen content are unique selling points.
- Established Market Presence: Loestrin Fe has a well-established presence in the market, contributing to its stability and growth potential.
Weaknesses
- High Cost: The drug is relatively expensive, which can be a barrier for some patients.
- Limited Generic Availability: Currently, there are no generic versions available for some formulations, which can limit accessibility.
- Competition: The market is competitive, with other oral contraceptives available.
Opportunities
- Growing Demand for Birth Control: The ongoing demand for effective birth control methods presents an opportunity for growth.
- Expansion into New Markets: There is potential to expand into new markets, especially in regions where access to birth control is limited.
- Patient Assistance Programs: Offering more patient assistance programs can increase accessibility and market share.
Threats
- Regulatory Changes: Changes in regulatory policies can impact the drug's market exclusivity and approval status.
- Emerging Competitors: New oral contraceptives entering the market could pose a threat to Loestrin Fe's market share.
- Economic Factors: Economic downturns or changes in healthcare policies can affect the affordability and accessibility of the drug.
Key Takeaways
- Loestrin Fe is a well-established oral contraceptive with a strong market presence.
- The drug's unique formulation and dosing regimen set it apart in the market.
- Pricing is a significant factor, with various discount programs and patient assistance options available.
- Understanding the regulatory and patent landscape is crucial for planning future strategies.
- The market forecast indicates stable growth, driven by the drug's efficacy and ongoing demand.
FAQs
1. What is Loestrin Fe used for? Loestrin Fe is used for the prevention of pregnancy in women. It is a low-dose oral contraceptive that combines ethinyl estradiol and norethindrone acetate.
2. How much does Loestrin Fe cost? The cost of Loestrin Fe can vary depending on the formulation and pharmacy. For example, Lo Loestrin Fe can cost around $955 for a supply of 140 tablets, while Loestrin Fe 1/20 can cost approximately $1,056 for the same quantity.
3. Are there any generic versions of Loestrin Fe available? Currently, there are no generic versions available for some formulations of Loestrin Fe. However, it is important to be cautious of fraudulent online pharmacies that may offer counterfeit generic versions[5].
4. What are the unique features of Loestrin Fe? Loestrin Fe has a unique dosing regimen and contains low doses of estrogen, which sets it apart from other oral contraceptives. For example, Lo Loestrin Fe includes a regimen of 24 days of tablets containing ethinyl estradiol and norethindrone acetate, followed by 2 days of tablets containing ethinyl estradiol, and finally 2 days of tablets containing ferrous fumarate.
5. What patient assistance programs are available for Loestrin Fe? Various patient assistance programs are available, including copay cards, savings programs, and discount cards like the Drugs.com Discount Card, which can save patients up to 80% on prescription medicines.
Sources
- ResearchAndMarkets.com, "Global Loestrin 24 Fe- Drug Insights, 2019-2021: MOA, Target, Dosage, Route of Administration, Molecule Type, Strength, Chemical Type, and ATC Classification", November 28, 2019.
- Drugs.com, "Lo Loestrin Fe Prices, Coupons, Copay Cards & Patient Assistance".
- FDA, "Clinical Review NDA 22-501 (Class 2 Resubmission) October 4, 2010 (Final)".
- Drugs.com, "Loestrin Fe 1/20 Prices, Coupons, Copay Cards & Patient Assistance".
- Drugs.com, "Generic Loestrin Fe 1.5/30 Availability".
More… ↓
